ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Psychiatry

Top Psychiatry Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MOHAMMED JEEWA MD

Psychiatry

2,903

$850K

110
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 25%

$293
Average prescription price

Avg: $113

JAHANBAKHSH NASSERZARE M.D.

Psychiatry

8,554

$839K

475
74 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 25%

$98
Average prescription price

Avg: $113

BERNARDO GARCIA-GRANDA M.D.

Psychiatry

9,270

$820K

641
446 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$88
Average prescription price

Avg: $113

SAJIDA MATHEW MD

Psychiatry

4,923

$820K

218
24 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 25%

$167
Average prescription price

Avg: $113

EDWARD ROSA MD

Psychiatry

8,810

$819K

592
284 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$93
Average prescription price

Avg: $113

SCOTT HALTZMAN MD

Psychiatry

6,276

$814K

422
47 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$130
Average prescription price

Avg: $113

YANIQUE DUVAL M.D.

Psychiatry

7,635

$803K

676
222 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$105
Average prescription price

Avg: $113

RIGOBERTO RODRIGUEZ M.D.

Psychiatry

32,237

$798K

2501
1905 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$25
Average prescription price

Avg: $113

LEONARDO ALONSO M.D.

Psychiatry

8,958

$797K

810
511 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$89
Average prescription price

Avg: $113

ANAIMALAI NANJUNDASAMY MD

Psychiatry

4,617

$791K

454
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$171
Average prescription price

Avg: $113

PETER VENTRE MD

Psychiatry

6,919

$790K

781
244 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$114
Average prescription price

Avg: $113

ALVARO MANOTAS MD

Psychiatry

9,738

$784K

458
195 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$81
Average prescription price

Avg: $113

ALAN FELDMAN M.D.

Psychiatry

7,850

$783K

623
205 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$100
Average prescription price

Avg: $113

STEVEN MACHLIN M.D.

Psychiatry

6,360

$781K

498
333 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$123
Average prescription price

Avg: $113

SHEHZAD NIAZI MD

Psychiatry

4,988

$778K

313
88 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 25%

$156
Average prescription price

Avg: $113

MALCOLM ROBERTS M.D.

Psychiatry

5,733

$778K

549
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$136
Average prescription price

Avg: $113

JOSE MONTES MD

Psychiatry

4,821

$777K

453
104 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$161
Average prescription price

Avg: $113

THOMAS VALENTE MD

Psychiatry

3,487

$768K

391
96 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 25%

$220
Average prescription price

Avg: $113

TAKKALLAPELLI RAO

Psychiatry

6,052

$761K

568
97 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$126
Average prescription price

Avg: $113

VERONICA MOTIRAM MD

Psychiatry

9,164

$757K

650
321 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $113

REMIGIO VILLEGAS M.D.

Psychiatry

7,882

$751K

533
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 25%

$95
Average prescription price

Avg: $113

RENATO ALCALDE MD

Psychiatry

4,001

$747K

279
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$187
Average prescription price

Avg: $113

IVAN MAZZORANA MD

Psychiatry

6,660

$742K

644
387 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$111
Average prescription price

Avg: $113

DANIEL CHERVONY MD

Psychiatry

5,891

$729K

406
250 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 25%

$124
Average prescription price

Avg: $113

STEVEN KANFER M.D.

Psychiatry

4,022

$725K

177
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$180
Average prescription price

Avg: $113

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank